Jodi V. Mones

441 total citations
21 papers, 283 citations indexed

About

Jodi V. Mones is a scholar working on Internal Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jodi V. Mones has authored 21 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Internal Medicine, 7 papers in Oncology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jodi V. Mones's work include Venous Thromboembolism Diagnosis and Management (7 papers), Platelet Disorders and Treatments (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Jodi V. Mones is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (7 papers), Platelet Disorders and Treatments (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Jodi V. Mones collaborates with scholars based in United States, Switzerland and Germany. Jodi V. Mones's co-authors include Gerald A. Soff, Montreh Tavakkoli, Michael J. Mauro, Simon Mantha, Sean M. Devlin, Yimei Miao, Debra Sarasohn, Rekha Parameswaran, Jonathan Wills and Ghassan K. Abou‐Alfa and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jodi V. Mones

20 papers receiving 281 citations

Peers

Jodi V. Mones

HEMAT

ONCOL

CCM

GENET

Shankaranarayana Paneesha United Kingdom

Sudha Parasuraman United States

Alexander T. Hardy United Kingdom

L. Robert Hanrahan United States

Simon Soudet France

Greg Hapgood Australia

Bosko Andjelic Serbia

Anna Christoforidou Greece

Granada Perea Spain

Barbara Eifrig Germany

Shankaranarayana Paneesha United Kingdom

Jodi V. Mones

86 ×0.8

HEMAT

67 ×0.7

ONCOL

112 ×1.3

63 ×1.0

CCM

36 ×0.9

GENET

Citations per year, relative to Jodi V. Mones Jodi V. Mones (= 1×) peers Shankaranarayana Paneesha

Countries citing papers authored by Jodi V. Mones

Since Specialization

Citations

This map shows the geographic impact of Jodi V. Mones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jodi V. Mones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jodi V. Mones more than expected).

Fields of papers citing papers by Jodi V. Mones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jodi V. Mones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jodi V. Mones. The network helps show where Jodi V. Mones may publish in the future.

Co-authorship network of co-authors of Jodi V. Mones

This figure shows the co-authorship network connecting the top 25 collaborators of Jodi V. Mones. A scholar is included among the top collaborators of Jodi V. Mones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jodi V. Mones. Jodi V. Mones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gilbert, Leah, et al.. (2022). Romiplostim for chemotherapy‐induced thrombocytopenia: Efficacy and safety of extended use. Research and Practice in Thrombosis and Haemostasis. 6(3). e12701–e12701. 10 indexed citations

George, James N., et al.. (2022). Occult recurrent breast cancer masquerading as thrombotic thrombocytopenic purpura. American Journal of Hematology. 98(5). 830–832.

Rotemberg, Veronica, et al.. (2022). Use of Asynchronous Interprofessional e-Consults in Cancer Patients During the COVID-19 Pandemic: Current and Future Role. Telemedicine Journal and e-Health. 29(2). 304–309. 1 indexed citations

Mones, Jodi V., Michael B. Streiff, Alok A. Khorana, et al.. (2021). Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial. Research and Practice in Thrombosis and Haemostasis. 5(5). e12549–e12549. 9 indexed citations

Connell, Nathan T., Inginia Genao, Janet P. Hafler, et al.. (2021). Diversity, Equity, and Inclusion in Hematology and Oncology Fellowship Programs. Blood. 138(Supplement 1). 2977–2977. 1 indexed citations

Dunbar, Andrew, Kelly L. Bolton, Sean M. Devlin, et al.. (2020). Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors. Blood. 137(15). 2103–2113. 66 indexed citations

Soff, Gerald A., Jodi V. Mones, Sean M. Devlin, et al.. (2019). Rivaroxaban treatment of cancer‐associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience. Research and Practice in Thrombosis and Haemostasis. 3(3). 349–356. 22 indexed citations

Tavakkoli, Montreh, et al.. (2019). A Novel Paradigm Between Leukocytosis, G-CSF Secretion, Neutrophil-to-Lymphocyte Ratio, Myeloid-Derived Suppressor Cells, and Prognosis in Non-small Cell Lung Cancer. Frontiers in Oncology. 9. 295–295. 53 indexed citations

Mones, Jodi V. & Gerald A. Soff. (2019). Management of Thrombocytopenia in Cancer Patients. Cancer treatment and research. 179. 139–150. 20 indexed citations

10.

Soff, Gerald A., Yimei Miao, Jodi V. Mones, et al.. (2019). Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia. Journal of Clinical Oncology. 37(31). 2892–2898. 63 indexed citations

11.

Rubinstein, Maria M., Cheryl Goss, Scott T. Avecilla, et al.. (2019). Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness. SHILAP Revista de lepidopterología. 8(2). 289–292. 5 indexed citations

12.

Dunbar, Andrew, Kelly L. Bolton, Sean M. Devlin, et al.. (2019). Extended Mutational Profiling By MSK-IMPACTTM Identifies Mutations Predicting Thromboembolic Risk in Patients with Solid Tumor Malignancy. Blood. 134(Supplement_1). 633–633. 1 indexed citations

13.

Tavakkoli, Montreh, et al.. (2018). The Significance of Leukocytosis in Malignancies: A Novel Paradigm Between Leukocytosis, G-CSF, Myeloid-Derived Suppressor Cells and Prognosis. Blood. 132(Supplement 1). 4944–4944. 3 indexed citations

14.

Soff, Gerald A., Debra Sarasohn, Eva Haegler‐Laube, et al.. (2018). Safe and Effective Use of Rivaroxaban for Treatment of Cancer Associated Venous Thromboembolic Disease. Blood. 132(Supplement 1). 2536–2536. 3 indexed citations

15.

Soff, Gerald A., Debra Sarasohn, Jodi V. Mones, et al.. (2018). Cancer-Associated Thrombosis: Anatomic Distribution of the Index Event Is Not a Reliable Predictor of Recurrence Risk. Blood. 132(Supplement 1). 1252–1252. 1 indexed citations

16.

Soff, Gerald A., Yimei Miao, Sean M. Devlin, et al.. (2017). Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT). Results of a Phase 2 Trial. Blood. 130. 289–289. 5 indexed citations

17.

Soff, Gerald A., Rekha Parameswaran, Simon Mantha, Yimei Miao, & Jodi V. Mones. (2016). Romiplostim management of chemotherapy-induced thrombocytopenia.. Journal of Clinical Oncology. 34(15_suppl). 10134–10134. 1 indexed citations

18.

Mones, Jodi V., Morton Coleman, Lale Kostakoğlu, et al.. (2007). Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement. Leukemia & lymphoma. 48(2). 342–348. 9 indexed citations

19.

Mones, Jodi V., Michael D. Coleman, Lale Kostakoğlu, et al.. (2004). A dose-escalation study of tositumomab and iodine I 131 tositumomab (Bexxar) in pts with previously treated non-Hodgkin's lymphoma (NHL) with > 25% bone marrow involvement. Journal of Clinical Oncology. 22(14_suppl). 6575–6575. 3 indexed citations

20.

Estivill, Xavier, et al.. (1984). [Thymoma associated with erythroblastopenia and hypogammaglobulinemia with an increase in the T8+ lymphocyte subpopulation].. PubMed. 82(7). 334–334. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact